|
|
|
LAVAL, QUEBEC--(Marketwire - Nov. 13, 2009) - Warnex Inc. (TSX:WNX) announced today financial results for the third quarter ended September 30, 2009. Operating Highlights - Signed an exclusive distribution agreement with...
Prometheus Laboratories Inc. has announced the nationwide commercial launch of ProOnc Mesothelioma Dx and two other cancer diagnostic products, ProOnc TumorSource Dx and ProOnc Squamous Dx. All three tests are based on highly...
7:57AM Gymboree reports Oct same store sales of -4%; now sees Q3 EPS of $1.10-$1.13 (vs $1.10 consensus), up from the co's precious range of $1.05-$1.10 43.53 : The co reported Q3 sales of $256.6 mln vs $273.5 mln consensus....
Company Notes Amylin Pharmaceuticals (San Diego, CA) and Takeda Pharmaceutical (Osaka, Japan) entered into a drug-development pact for the treatment of obesity and related indications. Ligand Pharmaceuticals (San Diego, CA)...
15-Year Johnson&Johnson Veteran to Lead microRNA Company -- Rosetta Genomics, Ltd. (Nasdaq: ROSG), a leading developer of microRNA-based molecular diagnostics, today announced the appointment of Kenneth A. Berlin to the...
Rosetta Genomics (NASDAQ: ROSG) today announced that Ayelet Chajut, its Executive Vice President, R&D, Head of Molecular Biology will speak at the 6th International Conference on Circulating Nucleic Acids in Plasma and Serum...
Rosetta Genomics, Ltd., a leading developer of microRNA-based molecular diagnostics, and Genetic Technologies Limited (GTG), the leading private genetic testing laboratory in Australia, announced today the signing of an...
7:55AM New York Times beats by $0.17, beats on revs 8.75 : Reports Q3 (Sep) earnings of $0.16 per share, excluding severance and other items, $0.17 better than the First Call consensus of ($0.01); revenues fell 16.9% year/year...
Super Religare Laboratories Limited (SRL) is India’s largest diagnostics network, and it has signed an exclusive marketing agreement with Rosetta Genomics for the distribution of miRview tests in India, Qatar, Saudi Arabia and...
SAN DIEGO, Oct. 15 /PRNewswire/ -- Prometheus Laboratories Inc., a specialty pharmaceutical and diagnostic company, today announced the nationwide commercial launch of three new cancer diagnostic products: ProOnc TumorSource...
